# Liquid Biopsy for Detection of Driver Mutation in NSCLC

> **NCT02778854** · — · UNKNOWN · sponsor: **Chinese PLA General Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **GENETIC:** detection of driver mutation

## Key facts

- **NCT ID:** NCT02778854
- **Lead sponsor:** Chinese PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-10
- **Primary completion:** 2018-12
- **Final completion:** 2020-11
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2018-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02778854

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02778854, "Liquid Biopsy for Detection of Driver Mutation in NSCLC". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT02778854. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*